In one paragraphArticle in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Ya'ara Negev-KoremDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.ORCID 0009-0009-3911-1043 Hadar Golan-BermanDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.ORCID 0000-0002-3372-9717 Elisheva HeilbrunDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Subhendu KarmakarInstitute for Drug Research, School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.ORCID 0000-0002-4840-3015 Yoram SorokaThe Myers Skin Research Laboratory, Institute for Drug Research, School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9103401, Israel.
Marina Frušić-ZlotkinThe Myers Skin Research Laboratory, Institute for Drug Research, School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9103401, Israel.ORCID 0000-0001-7142-3359 Ofer ChenDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.ORCID 0009-0009-5603-983X Hiba HassanainDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Esther SternGene Therapy Institute, Hadassah Medical Center, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Ori WaldGene Therapy Institute, Hadassah Medical Center, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Dan GibsonInstitute for Drug Research, School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.ORCID 0000-0002-1631-4018 Ron KohenThe Myers Skin Research Laboratory, Institute for Drug Research, School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9103401, Israel.ORCID 0000-0001-7268-9845 Sheera AdarDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.ORCID 0000-0002-9767-3740 Funding
Israel Cancer Association 20191630, 20210078Israel Science Foundation 1710/17, 482/22, 1002/18, 1728/20the Alex Grass Center for Drug Design and Novel Therapeutics 3175006046
6 · The paper itselfAbstract
Indexed as
Antineoplastic AgentsChromatinCisplatinDrug Resistance, NeoplasmExcision RepairProdrugsCell Line, TumorDNA DamageDNA RepairHumansAntineoplastic AgentsChromatinCisplatinProdrugschromatincisplatinDNA damageDNA repairKDACNrf2nucleotide excision repairPt(IV)
Identifiers
PMID42072663
PMCPMC13113776
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390